Open Journal of Rheumatology and Autoimmune Diseases
Vol.2 No.3(2012), Paper ID 21767, 6
pages
DOI:10.4236/ojra.2012.23011
Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia
Eric L. Matteson, Tim Bongartz, Jay H. Ryu, Cynthia S. Crowson, Thomas E. Hartman, Paul F. Dellaripa
Division of Rheumatology, Milano, Italy
Division of Rheumatology, Milano, Italy
Division of Pulmonary and Critical Care Medicine
Department of Health Sciences Research
Department of Radiology, Mayo Clinic College of Medicine, Rochester , US
Division of Rheumatology, Brigham and Womens Hospital, Boston, US
Copyright © 2012 Eric L. Matteson, Tim Bongartz, Jay H. Ryu, Cynthia S. Crowson, Thomas E. Hartman, Paul F. Dellaripa et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
E. Matteson, T. Bongartz, J. Ryu, C. Crowson, T. Hartman and P. Dellaripa, "Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia,"
Open Journal of Rheumatology and Autoimmune Diseases, Vol. 2 No. 3, 2012, pp. 53-58. doi:
10.4236/ojra.2012.23011.